Nxstage Medical (NXTM) Reports In-Line Q4 EPS; Issues Light FY16 Revenue Outlook

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/23/2026

1. KBH
2. PATH
3. AZO
4. SPY
5. PLTR
6. RCL
7. ONON
8. QQQ
9. PRGS
10. ORCL

Go back to Nxstage Medical (NXTM) Reports In-Line Q4 EPS; Issues Light FY16 Revenue Outlook

Piper Jaffray Cuts Price Target on Nxstage Medical (NXTM) Following Mixed 4Q Results

February 11, 2016 9:23 AM EST

Piper Jaffray maintained an Overweight rating on NxStage Medical (NASDAQ: NXTM), and cut the price target to $23.00 (from $24.00), following the company's 4Q earnings report. Revenue exceeded expectations, while net loss was in-line with Street estimates. 2016 revenue guidance was lower than Street estimates due to a $20M... More